UnitedHealth Group Incorporated $UNH Shares Bought by Pinnacle West Asset Management Inc.

Pinnacle West Asset Management Inc. grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the second quarter, HoldingsChannel reports. The fund owned 7,210 shares of the healthcare conglomerate’s stock after purchasing an additional 95 shares during the period. UnitedHealth Group accounts for about 1.6% of Pinnacle West Asset Management Inc.’s investment portfolio, making the stock its 18th biggest holding. Pinnacle West Asset Management Inc.’s holdings in UnitedHealth Group were worth $2,249,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in UNH. Nuveen LLC purchased a new position in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its stake in UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. National Bank of Canada FI grew its stake in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after buying an additional 847,054 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday. Barclays raised their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research note on Thursday. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, KeyCorp lifted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Stock Down 3.6%

UnitedHealth Group stock opened at $354.30 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market cap of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47. The stock’s 50 day moving average price is $318.21 and its 200 day moving average price is $350.41.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the firm earned $6.80 earnings per share. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.